Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group.
about
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertensionBlood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertensionSystematic review: antihypertensive drug therapy in patients of African and South Asian ethnicityObesity-hypertension: an ongoing pandemic.Treatment of hypertension in obese patients.The role of the sympathetic nervous system in obesity-related hypertensionInsulin resistance and hypertension.Influence of West African Ethnicity and Gender on Beta-Cell Function and Insulin Sensitivity in Essential Hypertensives Treated with Hydrochlorothiazide and Hydrochlorothiazide-lisinopril Combination.Pathophysiology of obesity hypertension.Role of sympathetic nervous system and neuropeptides in obesity hypertension.Effects of exercise training on mitochondrial function in patients with type 2 diabetes.Drug mechanisms to help in managing resistant hypertension in obesityObesity, hypertension, and sympathetic nervous system activity.Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trialImpact of the obesity epidemic on hypertension and renal disease.Obesity and hypertension: two epidemics or one?Hypertension syndrome and cardiovascular events. High blood pressure is only one risk factor.Therapeutic considerations in the treatment of obesity hypertension.Obesity, essential hypertension and renin-angiotensin system.Optimizing blood pressure control in the obese patient.Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN Study.Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension.Obesity-induced hypertension: interaction of neurohumoral and renal mechanismsRenal angiotensin II receptors, hyperinsulinemia, and obesity.Systemic and renal-specific sympathoinhibition in obesity hypertension.Medical complications of obesity and optimization of the obese patient for colorectal surgery.Nondiabetic consequences of obesity on kidney.Diagnosis and management of hypertension in obesity.The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome.The treatment of hypertension in obese patients.Secondary hypertension: obesity and the metabolic syndrome.Neural mechanisms and management of obesity-related hypertension.Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsObesity, hypertension, and chronic kidney disease.Hypertension: physiology and pathophysiology.The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.Association of Thiazide-Type Diuretics With Glycemic Changes in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
P2860
Q24194532-35D5DA00-0CE5-4B15-9391-8304704DE2AFQ24240794-2A194878-7E81-419D-A165-A27B04403DDAQ26749491-5B346BA6-7C71-4715-9E08-104915D90C16Q30359525-1FFCCBDE-301C-41E0-B401-FAE7AF0C57DDQ30429298-B4955643-CB97-4F14-B3A1-E6100680B7CDQ33622500-77DD546A-7735-4E82-B726-A65B47F83C68Q33697707-316F327F-453A-4884-8156-EA1F30948DCAQ33872249-952BD172-DBC2-4131-B6E7-FFEEE7D085F7Q33917330-7A6817E4-70ED-46D5-98A9-98A96B9ABEDCQ33928291-36EAB0D8-BC14-44AA-891B-219A74B978C4Q34023559-604B97EE-147B-405B-BF4C-4D34B492A5DFQ34023578-2081B873-6F18-4C93-900F-F47FA5FF5624Q34028169-9B809664-3421-4509-8D75-5064FD1DFD80Q34222639-6ADCBAB7-A1C9-4E4B-960A-BAD39D1C9259Q34226559-231E4ECA-80DE-40D9-A414-3DB61D477542Q34311562-BDE03428-CC49-4B9C-BC3B-1AEBD5EC577FQ34452171-86D725E2-A254-4546-8C86-792AAC2DEF86Q34667635-C2DAF26D-5DCD-48A9-A2D6-B14981465C48Q34695154-7D136409-2EA4-40DA-A5C3-2CA0396441A4Q34824920-1D9D61F0-EFE3-4391-A708-14BC2505818EQ35005395-BBD05E29-BDD9-4F39-A063-0F683CF1BCA6Q35043124-C772C7CD-D776-4454-831E-F33C3048E4F4Q35186358-80CCB856-21F5-47B2-B01C-1BE4BC9D3D6BQ35574793-17B66417-4D8B-41FB-B565-89F484E026D4Q35751981-527C8BD2-1B63-4376-8CA4-0686AE814BA7Q35850150-9606E7E2-AFFA-49D6-813F-FF3E496AFCA0Q36402331-CDFFFA47-FAB8-4A11-921A-BBB8F9413985Q36455910-8995458F-195A-48FC-A8EC-E5C72CC741DDQ36901526-F71B0F54-3EBA-4C4E-A880-9E54718BDE7CQ37161468-17894FD8-02AE-4E35-A127-DBC9E6C55F1AQ37209322-D23BF6FE-B756-47CE-B412-0116FD7221FEQ37307980-8BFED2C8-A1AF-4E43-95CA-048B255D3D98Q37518344-D062D043-C14F-4B54-ABA2-6F8F4B06867CQ37601245-C7DF487E-DBB5-43BB-9AB7-BEE0E5F286C8Q38110492-1C7AF419-27E1-4D4E-A4C7-A0E873452E0CQ38332289-EEA7F21A-AAEE-4E75-B951-225F2EEC146EQ38444730-6949DBF3-A35E-42A0-BDBB-3689863A591FQ38591219-B52D9E54-FD2A-490F-BFC9-8DFA6E31E8DCQ38662797-FC40109C-D1EC-4629-97EA-FFA809773816Q39018887-AC93220E-A252-4689-B8F4-256842F7CBFA
P2860
Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Lisinopril versus hydrochlorot ...... rtension (TROPHY) Study Group.
@en
Lisinopril versus hydrochlorot ...... ese Patients With Hypertension
@nl
type
label
Lisinopril versus hydrochlorot ...... rtension (TROPHY) Study Group.
@en
Lisinopril versus hydrochlorot ...... ese Patients With Hypertension
@nl
prefLabel
Lisinopril versus hydrochlorot ...... rtension (TROPHY) Study Group.
@en
Lisinopril versus hydrochlorot ...... ese Patients With Hypertension
@nl
P2093
P921
P356
P1433
P1476
Lisinopril versus hydrochlorot ...... rtension (TROPHY) Study Group.
@en
P2093
D A Anzalone
H G Hutchinson
P304
P356
10.1161/01.HYP.30.1.140
P407
P433
P577
1997-07-01T00:00:00Z